RXRA and colonic neoplasm: We demonstrated here that t-RXRα, the truncated form of RXRα (Retinoid X Receptor α), sequestrates LXRβ in the cytoplasm of colon cancer cells, thus potentiating the cytotoxic effects of agonist treatment.